Search

Search Results

• 

  PO40 | RADAR, UK-MRA MYELOMA XV - COMPARING MRD-GUIDED TREATMENT ESCALATION AND DE-ESCALATION STRATEGIES IN PATIENTS WITH NEWLY DIAGNOSED MYELOMA SUITABLE FOR STEM CELL TRANSPLANTATION: THROMBOPROPHYLAXIS SUBGROUP STUDY PROTOCOL Z. Sayar, on behalf of the RADAR Investigators | Whittington Health NHS Trust and Royal Free Hospital, London, UK

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.534

  97

  PDF: 22
• 

  OC04 | DIRECT ORAL ANTICOAGULANTS PROVIDE EFFECTIVE THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA: REAL WORLD FINDINGS FROM THE ATOMM STUDY T. Bull¹, Heamstar Collaborators², W. Wilson³, E. Ganendra⁴, M. Thomas⁵, R. Alikhan⁶, M. Karanth¹, M. Camilleri⁷ | ¹West Suffolk Hospital NHS Foundation Trust, UK; ²Haematology Specialty Training Audit and Research HaemSTAR Network, UK; ³University College London Clinical Trial Centre, UK; ⁴North West Anglia NHS Foundation Trust, UK; ⁵University College London Hospitals, UK; ⁶Cardiff and Vale University Health Board, Wales, UK; ⁷Cambridge University Hospitals NHS Foundation Trust, UK

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.488

  115

  PDF: 28
• 

  PO56 | EXTERNAL VALIDATION OF THE SAVED SCORE IN A CANADIAN REGIONAL CANCER CENTER COHORT: A REAL-WORLD ANALYSIS A. Naassan, R. Fatima, M. Naassan, C. Chisholm | Lakeridge Health, R.S. McLaughlin Durham Regional Cancer Centre, Department of Oncology, Oshawa, ON, Canada

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.548

  202

  PDF: 36
• 

  OC03 | THROMBOEMBOLIC PREVALENCE IN MULTIPLE MYELOMA BEFORE AND AFTER THE INTRODUCTION OF DIRECT ORAL ANTICOAGULANTS: A LONGITUDINAL COHORT STUDY A. Ramírez¹, A. Orozco², A. Sánchez³, F. Villalpa¹, S. Burgos², G. Cesarman³, G. Rodríguez¹, D. Vieyra², J. Álvarez⁴, G.M. Flores³, S. González¹, D. Martínez², B. Cabello³, R. Espinoza³, O. Fernández³ | ¹Myeloma-clinic Hematology service, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, México City, México; ²Myeloma-clinic Hematology service, Instituto Nacional de Nutrición Salvador Zubirán, México City, México; ³Myeloma-clinic Hematology service, Instituto Nacional de Cancerologçia, México City, Mexico; ⁴Centro Médico Nacional 20 de Noviembre, México City, Mexico

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.487

  110

  PDF: 26
• 

  PO41 | VENOUS THROMBOEMBOLISM IN PERIPHERAL BLOOD STEM CELL COLLECTION. A SINGLE CENTER EXPERIENCE P. Holly¹, J. Hudecek¹, J. Chudej¹, L. Valekova¹, I. Plamenova¹, E. Flochova¹, R. Simonova¹, J. Sokol¹, J. Stasko¹, M. Pietrzykova^1|2, E. Vescecikova² | ¹Department of Hematology and Transfusion Medicine, University Hospital in Martin, Martin, Slovakia; ²National Transfusion Service, Martin, Slovakia

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.535

  111

  PDF: 21
• 

  A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

  Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

  09-03-2023

  https://doi.org/10.4081/btvb.2023.53

  1184

  PDF: 471
• 

  Preface to the 13^th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2026

  Anna Falanga, Benjamin Brenner, Alok A. Khorana

  16-04-2026

  https://doi.org/10.4081/btvb.2026.479

  147

  PDF: 95

• PO81 | Direct oral anticoagulants in atypical site vein thrombosis: a single centre experience focused on cancer patients U. Mazzarelli¹, A. Guida¹, L. Agrelli¹, M. Amato¹, R. Guarrasi², L. Santaniello², C. Cardamone¹, P. Vitale¹, M. Triggiani¹ | ¹Centro per le Malattie Emorragiche Congenite e Malattie Trombotiche UOC Clinica Immunologica e Reumatologica AOU S. Giovanni di Dio e Ruggi d’Aragona, Salerno; ²UOC Clinica Oncologica AOU S. Giovanni di Dio e Ruggi d’Aragona, Salerno, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.350

  523

  PDF: 0

• PO22 | Early detection and management of PICC-related thrombosis in oncohematologic patients through serial ultrasound monitoring: a prospective observational study S. Laurenti, M. Schneeberger, G. Rosati, A. Pozzi, M. Padrini, R. Vacchelli, A. Morotti | University of Turin, AUO San Luigi Gonzaga, Orbassano (TO), Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.282

  475

  PDF: 0

• PO08 | Efficacy and safety of thromboprophylaxis in hospitalized hematological patients: a monocenter retrospective study S. Cordella^1,2, V. Coluccio³, M. Luppi¹, M. Marietta¹ |  ¹Department of Medical and Surgical Sciences, Section of Hematology. University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena; ²Clinical and Experimental Medicine PhD Programme, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena; ³Department of Hematology, Unità Sanitaria Locale di Modena, Italy 

  22-10-2025

  https://doi.org/10.4081/btvb.2025.270

  451

  PDF: 0
• 

  PO18 | THE THROMBO-INFLAMMATION AXIS AS PREDICTOR OF TOXICITY IN PATIENTS TREATED WITH CAR-T CELLS C. Fernández-Arias¹, M. Marcos-Jubilar¹, M. Panizo¹, C. Vázquez-Puerta², J.R. González-Porras², M. Ibáñez¹, A. Queralt¹, M. Carrasco¹, M.B. Villacrés¹, C. Conde¹, P. Elizalde¹, S. Huerga¹, A. Alfonso¹, P. Rodríguez-Otero¹, S. Villar¹, M.A. Canales¹, J. Rifón¹, F. Prósper¹, J.A. Páramo¹, J. Orbe¹, R. Lecumberri¹ | ¹Clínica Universidad de Navarra, Pamplona; ²Hospital Clínico Universitario de Salamanca, Salamanca, Spain

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.513

  123

  PDF: 30